Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03796052 · ClinicalTrials.gov registry record · NA
Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients
A NA study of Pruritus and Ichthyosis, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT03796052 is a NA study of Pruritus and Ichthyosis that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 53 participants, below the 107-participant average among 12 other Pruritus trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03796052, a NA study of Pruritus and Ichthyosis, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the safety and efficacy of three topical agents containing oat kernel flour to determine how well they relieve skin dryness and itching related to cancer therapies. Participants will receive a body wash, a body cream, and an anti-itch balm to use at home for 4-6 weeks.
Conditions Studied
Interventions
- OTHER Avena Sativa Skincare Regimen
Study Locations (1)
New York
- Memorial Sloan-Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2019-05-23 |
| Est. Completion | 2019-12-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03796052
The ClinicalTrials.gov registry entry for NCT03796052 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 107-participant average among 12 other Pruritus trials with a reported enrollment target (50% lower). The listed sponsor is Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pruritus appearing as the primary indexed condition, and to 1 intervention - of which Avena Sativa Skincare Regimen is the first listed.
NCT03796052 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03796052 about?
NCT03796052 is a clinical study titled "Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients". This study will test the safety and efficacy of three topical agents containing oat kernel flour to determine how well they relieve skin dryness and itching related to cancer therapies. Participants will receive a body wash, a body cream, and an anti-itch balm to use at home for 4-6 weeks.
What is the current status of trial NCT03796052?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2019-05-23. Estimated completion is 2019-12-18.
What conditions does trial NCT03796052 study?
This clinical trial studies the following conditions: Pruritus, Ichthyosis.
What interventions are being tested in trial NCT03796052?
The interventions under investigation include: Avena Sativa Skincare Regimen (OTHER).
Who is sponsoring clinical trial NCT03796052?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03796052 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pruritus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis
RECRUITING · NA
-
VR-PMR for Post-Burn Symptoms
RECRUITING · NA
-
Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch
RECRUITING · NA
-
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
RECRUITING · Phase 3
-
Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic Stimuli
COMPLETED · Early Phase 1
-
Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.